Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Numerate, a US-based biotechnology company, has completed a $5.5 million series B financing.
Subscribe to our email newsletter
Foundation Capital led the round and was joined by Lanza techVentures, both existing investors.
Guido Lanza, president and CEO of Numerate, said: “This investment will help support our business model of partnering with biotechnology and pharmaceutical companies while building on our drug design platform that provides compounds with the best chance of succeeding in the lab, clinic and marketplace.”